Treatment of chronic pelvic pain in men and women

References Papers of special note have been highlighted as: • of interest •• of considerable interest

• Krieger JN, Ross SO, Riley DE. Chronic prostatitis: epidemiology and role of infection. Urology60(6 Suppl.), 8–12; discussion 13 (2002).
   PubMedGoogle Scholar
• Calhoun EA, McNaughton Collins M, Pontari MA et al. The economic impact of chronic prostatitis. Arch. Intern. Med.164(11), 1231–1236 (2004).
   PubMedGoogle Scholar
• Krieger JN, Nyberg L Jr, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA282(3), 236–237 (1999).
   PubMed Web of Science ®Google Scholar
• Litwin MS, McNaughton-Collins M, Fowler FJ Jr et al. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J. Urology162(2), 369–375 (1999).
   PubMed Web of Science ®Google Scholar
• Grace V, Zondervan K. Chronic pelvic pain in women in New Zealand: comparative well-being, comorbidity, and impact on work and other activities. Health Care Women Int.27(7), 585–599 (2006).
   PubMedGoogle Scholar
• Williams RE, Hartmann KE, Steege JF. Documenting the current definitions of chronic pelvic pain: implications for research. Obstet. Gynecol.103(4), 686–691 (2004).
   PubMed Web of Science ®Google Scholar
• Leserman J, Zolnoun D, Meltzer-Brody S, Lamvu G, Steege JF. Identification of diagnostic subtypes of chronic pelvic pain and how subtypes differ in health status and trauma history. Am. J. Obstet. Gynecol.195(2), 554–560; discussion 560–561 (2006).
   PubMed Web of Science ®Google Scholar
• Lamvu G, Williams R, Zolnoun D et al. Long-term outcomes after surgical and nonsurgical management of chronic pelvic pain: one year after evaluation in a pelvic pain specialty clinic. Am. J. Obstet. Gynecol.195(2), 591–598; discussion 598–600 (2006).
   PubMed Web of Science ®Google Scholar
• Poleshuck EL, Dworkin RH, Howard FM et al. Contributions of physical and sexual abuse to women’s experiences with chronic pelvic pain. J. Reprod. Med.50(2), 91–100 (2005).
   PubMed Web of Science ®Google Scholar
• Ballard K, Lowton K, Wright J. What’s the delay? A qualitative study of women’s experiences of reaching a diagnosis of endometriosis. Fertil. Steril.86(5), 1296–1301 (2006).
   PubMed Web of Science ®Google Scholar
• Nickel JC, Pontari M, Moon T et al. A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis. J. Urol.169(4), 1401–1405 (2003).
   PubMed Web of Science ®Google Scholar
• Nickel JC, Forrest JB, Tomera K et al. Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study. J. Urol.173(4), 1252–1255 (2005).
   PubMed Web of Science ®Google Scholar
• Wiffen P, Collins S, McQuay H, Carroll D, Jadad A, Moore A. Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst. Rev.(3), CD001133 (2005).
   Google Scholar
• Sasaki K, Smith CP, Chuang YC, Lee JY, Kim JC, Chancellor MB. Oral gabapentin (neurontin) treatment of refractory genitourinary tract pain. Tech. Urol.7(1), 47–49 (2001).
   PubMedGoogle Scholar
• Sator-Katzenschlager SM, Scharbert G, Kress HG et al. Chronic pelvic pain treated with gabapentin and amitriptyline: a randomized controlled pilot study. Wien. Klin. Wochenschr.117(21–22), 761–768 (2005).
   PubMed Web of Science ®Google Scholar
• Sindrup SH, Otto M, Finnerup NB, Jensen TS. Antidepressants in the treatment of neuropathic pain. Basic Clin. Pharmacol. Toxicol.96(6), 399–409 (2005).
   PubMed Web of Science ®Google Scholar
• Engel CC Jr, Walker EA, Engel AL, Bullis J, Armstrong A. A randomized, double-blind crossover trial of sertraline in women with chronic pelvic pain. J. Psychosom. Res.44(2), 203–207 (1998).
   PubMed Web of Science ®Google Scholar
• Lee RA, West RM, Wilson JD. The response to sertraline in men with chronic pelvic pain syndrome. Sex. Transm. Infect.81(2), 147–149 (2005).
   PubMedGoogle Scholar
• Trescot AM, Boswell MV, Atluri SL et al. Opioid guidelines in the management of chronic non-cancer pain. Pain Physician9(1), 1–39 (2006).
   PubMedGoogle Scholar
• Fishman SM, Kreis PG. The opioid contract. Clin. J. Pain18(4 Suppl.), S70–S75 (2002).
   PubMed Web of Science ®Google Scholar
• Cheah PY, Liong ML, Yuen KH et al. Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial. J. Urol.169(2), 592–596 (2003).
   PubMed Web of Science ®Google Scholar
• Cheah PY, Liong ML, Yuen KH et al. Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome. Urology64(5), 881–886 (2004).
   PubMedGoogle Scholar
• Mehik A, Alas P, Nickel JC, Sarpola A, Helstrom PJ. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study. Urology62(3), 425–429 (2003).
   PubMed Web of Science ®Google Scholar
• Nickel JC, Narayan P, McKay J, Doyle C. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial. J. Urol.171(4), 1594–1597 (2004).
   PubMed Web of Science ®Google Scholar
• Alexander RB, Propert KJ, Schaeffer AJ et al. Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann. Intern. Med.141(8), 581–589 (2004).
   PubMed Web of Science ®Google Scholar
• Nickel JC, Downey J, Clark J et al. Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial. Urology62(4), 614–617 (2003).
   PubMed Web of Science ®Google Scholar
• Attar E, Bulun SE. Aromatase inhibitors: the next generation of therapeutics for endometriosis? Fertil. Steril.85(5), 1307–1318 (2006).
   PubMed Web of Science ®Google Scholar
• Nickel JC, Downey J, Pontari MA, Shoskes DA, Zeitlin SI. A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis). BJU Int.93(7), 991–995 (2004).
   PubMed Web of Science ®Google Scholar
• Berkley KJ, Rapkin AJ, Papka RE. The pains of endometriosis. Science308(5728), 1587–1589 (2005).
   Google Scholar
• Szendei G, Hernadi Z, Devenyi N, Csapo Z. Is there any correlation between stages of endometriosis and severity of chronic pelvic pain? Possibilities of treatment. Gynecol. Endocrinol.21(2), 93–100 (2005).
   PubMed Web of Science ®Google Scholar
• Ling FW. Randomized controlled trial of depot leuprolide in patients with chronic pelvic pain and clinically suspected endometriosis. Pelvic Pain Study Group. Obstet. Gynecol.93(1), 51–58 (1999).
   PubMed Web of Science ®Google Scholar
• De Rose AF, Gallo F, Giglio M, Carmignani G. Role of mepartricin in category III chronic nonbacterial prostatitis/chronic pelvic pain syndrome: a randomized prospective placebo-controlled trial. Urology63(1), 13–16 (2004).
   PubMed Web of Science ®Google Scholar
• Moore J, Kennedy S, Prentice A. Modern combined oral contraceptives for pain associated with endometriosis. Cochrane Database Syst. Rev.(2), CD001019 (2000).
   Google Scholar
• Crosignani PG, Luciano A, Ray A, Bergqvist A. Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain. Hum. Reprod.21(1), 248–256 (2006).
   PubMed Web of Science ®Google Scholar
• Petta CA, Ferriani RA, Abrao MS et al. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis. Hum. Reprod.20(7), 1993–1998 (2005).
   PubMed Web of Science ®Google Scholar
• Lambert JJ, Belelli D, Peden DR, Vardy AW, Peters JA. Neurosteroid modulation of GABAA receptors. Prog. Neurobiol.71(1), 67–80 (2003).
   PubMed Web of Science ®Google Scholar
• Tugcu V, Tasci AI, Fazlioglu A et al. A placebo-controlled comparison of the efficiency of triple- and monotherapy in category III B chronic pelvic pain syndrome (CPPS). Eur. Urol.51(4), 1113–1118 (2006).
   PubMedGoogle Scholar
• Diokno AC, Homma Y, Sekiguchi Y, Suzuki Y. Interstitial cystitis, gynecologic pelvic pain prostatitis, and their epidemiology. Int. J. Urol.10(Suppl.), S3–S6 (2003).
   Google Scholar
• Mayer R. Interstitial cystitis pathogenesis and treatment. Curr. Opin. Infect. Dis.20(1), 77–82 (2007).
   PubMed Web of Science ®Google Scholar
• Toft BR, Nordling J. Recent developments of intravesical therapy of painful bladder syndrome/interstitial cystitis: a review. Curr. Opin. Urol.16(4), 268–272 (2006).
   PubMedGoogle Scholar
• Glemain P, Riviere C, Lenormand L, Karam G, Bouchot O, Buzelin JM. Prolonged hydrodistention of the bladder for symptomatic treatment of interstitial cystitis: efficacy at 6 months and 1 year. Eur. Urol.41(1), 79–84 (2002).
   PubMed Web of Science ®Google Scholar
• Zabihi N, Allee T, Maher MG et al. Bladder necrosis following hydrodistention in patients with interstitial cystitis. J. Urol.177(1), 149–152; discussion 152 (2007).
   PubMedGoogle Scholar
• Ottem DP, Teichman JM. What is the value of cystoscopy with hydrodistension for interstitial cystitis? Urology66(3), 494–499 (2005).
   PubMed Web of Science ®Google Scholar
• Kang SB, Chung HH, Lee HP, Lee JY, Chang YS. Impact of diagnostic laparoscopy on the management of chronic pelvic pain. Surg. Endosc. (2006) (Epub ahead of print).
   Google Scholar
• Cox L, Ayers S, Nala K, Penny J. Chronic pelvic pain and quality of life after laparoscopy. Eur. J. Obstet. Gynecol. Reprod. Biol. (2006) (Epub ahead of print).
   PubMedGoogle Scholar
• ACOG Practice Bulletin No. 51. Chronic pelvic pain. Obstet. Gynecol.103(3), 589–605 (2004).
   PubMed Web of Science ®Google Scholar
• ACOG Committee Opinion. Number 310, April 2005. Endometriosis in adolescents. Obstet. Gynecol.105(4), 921–927 (2005).
   PubMedGoogle Scholar
• Palter SF, Olive DL. Office microlaparoscopy under local anesthesia for chronic pelvic pain. J. Am. Assoc. Gynecol. Laparosc.3(3), 359–364 (1996).
   PubMedGoogle Scholar
• Swanton A, Iyer L, Reginald PW. Diagnosis, treatment and follow up of women undergoing conscious pain mapping for chronic pelvic pain: a prospective cohort study. Br. J. Obstet. Gynecol.113(7), 792–796 (2006).
   Google Scholar
• Jarrell JF, Vilos GA, Allaire C et al. Consensus guidelines for the management of chronic pelvic pain. J. Obstet. Gynecol. Can.27(8), 781–826 (2005).
   PubMedGoogle Scholar
• Martin DC. Hysterectomy for treatment of pain associated with endometriosis. J. Minim. Invasive Gynecol.13(6), 566–572 (2006).
   PubMedGoogle Scholar
• Behera M, Vilos GA, Hollett-Caines J, Abu-Rafea B, Ahmad R. Laparoscopic findings, histopathologic evaluation, and clinical outcomes in women with chronic pelvic pain after hysterectomy and bilateral salpingo-oophorectomy. J. Minim. Invasive Gynecol.13(5), 431–435 (2006).
   PubMed Web of Science ®Google Scholar
• Cummings TM, White AR. Needling therapies in the management of myofascial trigger point pain: a systematic review. Arch. Phys. Med. Rehabil.82(7), 986–992 (2001).
   PubMed Web of Science ®Google Scholar
• Candiani GB, Fedele L, Vercellini P, Bianchi S, Di Nola G. Presacral neurectomy for the treatment of pelvic pain associated with endometriosis: a controlled study. Am. J. Obstet. Gynecol.167(1), 100–103 (1992).
   PubMedGoogle Scholar
• Chen FP, Chang SD, Chu KK, Soong YK. Comparison of laparoscopic presacral neurectomy and laparoscopic uterine nerve ablation for primary dysmenorrhea. J. Reprod. Med.41(7), 463–466 (1996).
   PubMedGoogle Scholar
• Proctor ML, Latthe PM, Farquhar CM, Khan KS, Johnson NP. Surgical interruption of pelvic nerve pathways for primary and secondary dysmenorrhoea. Cochrane Database Syst. Rev.(4), CD001896 (2005).
   Google Scholar
• Johnson NP, Farquhar CM, Crossley S et al. A double-blind randomised controlled trial of laparoscopic uterine nerve ablation for women with chronic pelvic pain. Br. J. Obstet. Gynecol.111(9), 950–959 (2004).
   Google Scholar
• Palomba S, Russo T, Falbo A et al. Laparoscopic uterine nerve ablation versus vaginal uterosacral ligament resection in postmenopausal women with intractable midline chronic pelvic pain: a randomized study. Eur. J. Obstet. Gynecol. Reprod. Biol.129(1), 84–91 (2006).
   PubMed Web of Science ®Google Scholar
• Sundaraj SR, Johnstone C, Noore F, Wynn P, Castro M. Spinal cord stimulation: a seven-year audit. J. Clin. Neurosci.12(3), 264–270 (2005).
   PubMedGoogle Scholar
• Cameron T. Safety and efficacy of spinal cord stimulation for the treatment of chronic pain: a 20-year literature review. J. Neurosurg.100(3 Suppl. Spine), 254–267 (2004).
   PubMed Web of Science ®Google Scholar
• Haque R, Winfree C. Spinal nerve root stimulation. Neurosurg. Focus21(6), 1–7 (2006).
   Google Scholar
• Weiner RL. Peripheral nerve neurostimulation. Neurosurg. Clin. N. Am.14(3), 401–408 (2003).
   PubMedGoogle Scholar
• Brown JA, Pilitsis JG. Motor cortex stimulation. Pain Med.7(Suppl. 1), S140–S145 (2006).
   Web of Science ®Google Scholar
• Kumar K, Malik S, Demeria D. Treatment of chronic pain with spinal cord stimulation versus alternative therapies: cost–effectiveness analysis. Neurosurgery51(1), 106–115; discussion 115–106 (2002).
   PubMed Web of Science ®Google Scholar
• Brookoff D, Bennett DS. Neuromodulation in intractable interstitial cystitis and related pelvic pain syndromes. Pain Med.7(Suppl. 1), S166–S184 (2006).
   PubMedGoogle Scholar
• Palecek J, Willis WD. The dorsal column pathway facilitates visceromotor responses to colorectal distention after colon inflammation in rats. Pain104(3), 501–507 (2003).
   PubMed Web of Science ®Google Scholar
• Kapural L, Narouze SN, Janicki TI, Mekhail N. Spinal cord stimulation is an effective treatment for the chronic intractable visceral pelvic pain. Pain Med.7(5), 440–443 (2006).
   PubMed Web of Science ®Google Scholar
• MaLossi J, Chai TC. Sacral neuromodulation for the treatment of bladder dysfunction. Curr. Urol. Rep.3(1), 61–66 (2002).
   PubMedGoogle Scholar
• Peters KM, Konstandt D. Sacral neuromodulation decreases narcotic requirements in refractory interstitial cystitis. BJU Int.93(6), 777–779 (2004).
   PubMed Web of Science ®Google Scholar
• van Balken MR, Vandoninck V, Messelink BJ et al. Percutaneous tibial nerve stimulation as neuromodulative treatment of chronic pelvic pain. Eur. Urol.43(2), 158–163; discussion 163 (2003).
   PubMed Web of Science ®Google Scholar
• Stearns L, Boortz-Marx R, Du Pen S et al. Intrathecal drug delivery for the management of cancer pain: a multidisciplinary consensus of best clinical practices. J. Support. Oncol.3(6), 399–408 (2005).
   PubMedGoogle Scholar
• Burton AW, Rajagopal A, Shah HN et al. Epidural and intrathecal analgesia is effective in treating refractory cancer pain. Pain Med.5(3), 239–247 (2004).
   PubMed Web of Science ®Google Scholar
• Kumar K, Kelly M, Pirlot T. Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: long-term benefits and efficacy. Surg. Neurol.55(2), 79–86; discussion 86–78 (2001).
   PubMed Web of Science ®Google Scholar
• Du Pen S, Du Pen A, Hillyer J. Intrathecal hydromorphone for intractable nonmalignant pain: a retrospective study. Pain Med.7(1), 10–15 (2006).
   PubMed Web of Science ®Google Scholar
• White AR. A review of controlled trials of acupuncture for women’s reproductive health care. J. Fam. Plann. Reprod. Health Care29(4), 233–236 (2003).
   PubMedGoogle Scholar
• Lund I, Lundeberg T, Lonnberg L, Svensson E. Decrease of pregnant women’s pelvic pain after acupuncture: a randomized controlled single-blind study. Acta Obstet. Gynecol. Scand.85(1), 12–19 (2006).
   PubMed Web of Science ®Google Scholar
• Elden H, Ladfors L, Olsen MF, Ostgaard HC, Hagberg H. Effects of acupuncture and stabilising exercises as adjunct to standard treatment in pregnant women with pelvic girdle pain: randomised single blind controlled trial. Br. Med. J. (Clin. Res. Ed.)330(7494), 761 (2005).
   PubMed Web of Science ®Google Scholar
• Honjo H, Kamoi K, Naya Y et al. Effects of acupuncture for chronic pelvic pain syndrome with intrapelvic venous congestion: preliminary results. Int. J. Urol.11(8), 607–612 (2004).
   PubMedGoogle Scholar
• Chen R, Nickel JC. Acupuncture ameliorates symptoms in men with chronic prostatitis/chronic pelvic pain syndrome. Urology61(6), 1156–1159; discussion 1159 (2003).
   PubMed Web of Science ®Google Scholar
• Kaplan SA, Volpe MA, Te AE. A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome. J. Urol.171(1), 284–288 (2004).
   PubMed Web of Science ®Google Scholar
• Capodice JL, Bemis DL, Buttyan R, Kaplan SA, Katz AE. Complementary and alternative medicine for chronic prostatitis/chronic pelvic pain syndrome. Evid. Based Complement. Alternat. Med.2(4), 495–501 (2005).
   PubMed Web of Science ®Google Scholar
• Brown CS, Ling FW, Wan JY, Pilla AA. Efficacy of static magnetic field therapy in chronic pelvic pain: a double-blind pilot study. Am. J. Obstet. Gynecol.187(6), 1581–1587 (2002).
   PubMed Web of Science ®Google Scholar
• Leippold T, Strebel RT, Huwyler M, John HA, Hauri D, Schmid DM. Sacral magnetic stimulation in non-inflammatory chronic pelvic pain syndrome. BJU Int.95(6), 838–841 (2005).
   PubMedGoogle Scholar
• Rowe E, Smith C, Laverick L, Elkabir J, Witherow RO, Patel A. A prospective, randomized, placebo controlled, double-blind study of pelvic electromagnetic therapy for the treatment of chronic pelvic pain syndrome with 1 year of followup. J. Urol.173(6), 2044–2047 (2005).
   PubMed Web of Science ®Google Scholar
• Hawkins RS, Hart AD. The use of thermal biofeedback in the treatment of pain associated with endometriosis: preliminary findings. Appl. Psychophysiol. Biofeedback28(4), 279–289 (2003).
   PubMedGoogle Scholar
• Hetrick DC, Glazer H, Liu YW, Turner JA, Frest M, Berger RE. Pelvic floor electromyography in men with chronic pelvic pain syndrome: a case–control study. Neurourol. Urodyn.25(1), 46–49 (2006).
   PubMed Web of Science ®Google Scholar
• Cornel EB, van Haarst EP, Schaarsberg RW, Geels J. The effect of biofeedback physical therapy in men with chronic pelvic pain syndrome type III. Eur. Urol.47(5), 607–611 (2005).
   PubMed Web of Science ®Google Scholar
• Nadler RB. Bladder training biofeedback and pelvic floor myalgia. Urology60(6 Suppl), 42–43; discussion 44 (2002).
   PubMedGoogle Scholar
• Ye ZQ, Cai D, Lan RZ et al. Biofeedback therapy for chronic pelvic pain syndrome. Asian J. Androl.5(2), 155–158 (2003).
   PubMedGoogle Scholar
• Giubilei G, Mondaini N, Minervini A et al. Physical activity of men with chronic prostatitis/chronic pelvic pain syndrome not satisfied with conventional treatments – could it represent a valid option? The physical activity and male pelvic pain trial: a double-blind, randomized study. J. Urol.177(1), 159–165 (2007).
   PubMed Web of Science ®Google Scholar
• Anderson RU, Wise D, Sawyer T, Chan C. Integration of myofascial trigger point release and paradoxical relaxation training treatment of chronic pelvic pain in men. J. Urol.174(1), 155–160 (2005).
   PubMed Web of Science ®Google Scholar
• Anderson RU, Wise D, Sawyer T, Chan CA. Sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome: improvement after trigger point release and paradoxical relaxation training. J. Urol.176(4 Pt 1), 1534–1538; discussion 1538–1539 (2006).
   PubMed Web of Science ®Google Scholar
• Jarvis SK, Abbott JA, Lenart MB, Steensma A, Vancaillie TG. Pilot study of botulinum toxin type A in the treatment of chronic pelvic pain associated with spasm of the levator ani muscles. Aust. NZ J. Obstet. Gynaecol.44(1), 46–50 (2004).
   PubMed Web of Science ®Google Scholar
• Thomson AJ, Jarvis SK, Lenart M, Abbott JA, Vancaillie TG. The use of botulinum toxin type A (BOTOX) as treatment for intractable chronic pelvic pain associated with spasm of the levator ani muscles. Br. J. Obstet. Gynecol.112(2), 247–249 (2005).
   Google Scholar
• Abbott JA, Jarvis SK, Lyons SD, Thomson A, Vancaille TG. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial. Obstet. Gynecol.108(4), 915–923 (2006).
   PubMed Web of Science ®Google Scholar
• Shoskes DA, Hakim L, Ghoniem G, Jackson CL. Long-term results of multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome. J. Urol.169(4), 1406–1410 (2003).
   PubMed Web of Science ®Google Scholar
• Habermacher GM, Chason JT, Schaeffer AJ. Prostatitis/chronic pelvic pain syndrome. Annu. Rev. Med.57, 195–206 (2006).
   PubMedGoogle Scholar
• Meares EM, Stamey TA. Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest. Urol.5(5), 492–518 (1968).
   PubMedGoogle Scholar